
Company Info
Year Established2018
Contacts
Irene Griswold-Prenner, Ph.D.Co-Founder, CEO & CSO
Frank Kayser, Ph.D.
VP, Discovery
Company Description
Nitrase Therapeutics is a preclinical stage platform company developing disease modifying therapeutics against a novel class of enzymes to treat neurological, oncological, cardiovascular, and other inflammatory diseases.